Trials / Completed
CompletedNCT05331651
Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 480 (actual)
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the anti-nausea and vomiting effect between glycopyrronium in combination with tropisetron and normal saline in combination with tropisetron for patients receiving elective surgery under general anesthesia. Based on this study the investigators intend to explore the feasibility of using glycopyrronium as adjuvant drug to prevent postoperative nausea and vomiting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glycopyrronium in Combination With Tropisetron | Glycopyrronium (0.2mg) in Combination With Tropisetron (4mg) intravenously given at the ending of the surgery. |
| DRUG | Normal Saline in Combination With Tropisetron | Normal Saline in Combination With Tropisetron (4mg) intravenously given at the ending of the surgery. |
Timeline
- Start date
- 2022-04-21
- Primary completion
- 2023-06-30
- Completion
- 2023-06-30
- First posted
- 2022-04-15
- Last updated
- 2024-08-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05331651. Inclusion in this directory is not an endorsement.